Watermark

BGB-3111-1002

Completed

A Study to Investigate Zanubrutinib in Chinese Participants With B-cell Lymphoma

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-3111-1002

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

China Drug Trials ID Info icon SVG graphic used for tooltips or additional information.

CTR20160204

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / 75 Years

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / 75 Years

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan